The National Comprehensive Cancer Network (NCCN) guidelines recommend women begin MRI screening at age 25 to 40, depending on family history (first-degree relative with breast cancer) and genetic predisposition (BRCA1/2, p53 or pTEN mutations) (114). This evidence concerns the gene TP53 and breast carcinoma.